Literature DB >> 18382281

The novel cyclooxygenase-2 inhibitor GW637185X protects against l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.

Jose A Aguirre1, Giuseppina Leo, Raquel Cueto, Beth Andbjer, Alan Naylor, Andrew D Medhurst, Luigi F Agnati, Kjell Fuxe.   

Abstract

The possible neuroprotective role of a novel and highly selective cyclooxygenase-2 inhibitor GW637185X was studied in a model of acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced injury of nigrostriatal dopaminergic (DA) neurons in the mouse. Stereological and microdensitometrical analysis of nigral tyrosine hydroxylase-immunoreactive cell bodies and striatal tyrosine hydroxylase-immunoreactive terminals, respectively, showed that GW637185X exerted a full protection against MPTP-induced degeneration of the nigro-striatal pathway. In contrast to earlier studies, these findings demonstrate that acute inhibition of cyclooxygenase-2 can result in a full neuroprotective effect not only on nigral DA cell bodies, but also on striatal DA terminals in the mouse MPTP model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18382281     DOI: 10.1097/WNR.0b013e3282fb7898

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

1.  On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X(7) receptor antagonist A-438079.

Authors:  Daniel Marcellino; Diana Suárez-Boomgaard; María Dolores Sánchez-Reina; José A Aguirre; Takashi Yoshitake; Shimako Yoshitake; Beth Hagman; Jan Kehr; Luigi F Agnati; Kjell Fuxe; Alicia Rivera
Journal:  J Neural Transm (Vienna)       Date:  2010-04-13       Impact factor: 3.575

2.  Possible role of receptor heteromers in multiple sclerosis.

Authors:  A O Tarakanov; K G Fuxe; L F Agnati; L B Goncharova
Journal:  J Neural Transm (Vienna)       Date:  2009-02-20       Impact factor: 3.575

3.  Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease.

Authors:  Giuseppa Mudò; Johanna Mäkelä; Valentina Di Liberto; Timofey V Tselykh; Melania Olivieri; Petteri Piepponen; Ove Eriksson; Annika Mälkiä; Alessandra Bonomo; Minna Kairisalo; Jose A Aguirre; Laura Korhonen; Natale Belluardo; Dan Lindholm
Journal:  Cell Mol Life Sci       Date:  2011-10-08       Impact factor: 9.261

4.  Licofelone attenuates MPTP-induced neuronal toxicity: behavioral, biochemical and cellular evidence.

Authors:  Amit Gupta; Anil Kumar; S K Kulkarni
Journal:  Inflammopharmacology       Date:  2010-08-11       Impact factor: 4.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.